Today, Paxman publishes the March issue of its newsletter aimed at shareholders, investors and other interested parties.
In this issue, CEO Richard Paxman answers shareholders’ questions on the current operations of the company and its potential, as well as the content in the year-end report. Some of the topics covered are Paxman’s work to achieve national cost coverage in the United States and the importance of the new CPT codes for scalp cooling, estimated life span for installed systems, and how high the utilisation rate is in the US market.
The newsletter also includes information on strong activity in the United States as well as in the UK and internationally. Activity in the US during March included installation of 10 systems for Dana Farber Cancer Institute at Chestnut Hill, Massachusetts, and internationally the company delivered systems to markets including Brazil, Bulgaria, Israel and the Netherlands.
To read the newsletter and subscribe for upcoming issues, follow this link:
PAXMAN’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on PAXMANs website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.
